Referral for invasive procedures. o Implantable cardiac defibrillators. Valve surgery. Non-NHS agencies. Lifestyle. o Smoking and alcohol. 3.3.3 Relationships between the guideline and other NICE guidance NICE guidance that will be updated by this guideline: Chronic heart failure in in adults: management (2010) NICE guidline CG108 NICE technology appraisals to be incorporated in this guidance: Ivabradine for treating chronic heart failure (2012) NICE technology appraisal guidance 267. Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (2016) NICE technology appraisal [TA388] Related NICE technology appraisals: Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (2014) NICE technology appraisal guidance [TA314] Related NICE intervenetional procedures guidance Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death Related NICE guidelines: Medicines optimisation (2015) NICE guideline NG5 Patient experience in adult NHS services (2012) NICE guideline CG138 Medicines adherence (2009) NICE guideline CG76 Acute heart failure: diagnosis and management (2014) Nice guideline [CG187] Chronic Heart Failure Methods NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 This chapter sets out in detail the methods used to review the evidence and to develop the recommendations that are presented in subsequent chapters of this guideline. This guidance was developed in accordance with the methods outlined in the NICE guidelines manual, 2014 version.236 Sections 4.1 to 4.3 describe the process used to identify and review clinical evidence (summarised in Figure 3), sections 4.2 and 4.4 describe the process used to identify and review the health economic evidence, and section 4.5 describes the process used to develop recommendations. 